A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial
Work
Year: 2024
Type: article
Abstract: Microneedle patches (MNPs) have been ranked as the highest global priority innovation for overcoming immunisation barriers in low-income and middle-income countries. This trial aimed to provide the fi... more
Source: The Lancet
Institutions MRC Unit the Gambia, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Micron Biomedical (United States), Center for Global Health
Cites: 27
Cited by: 28
Related to: 10
FWCI: 18.05
Citation percentile (by year/subfield): 99.96
Subfield: Pharmaceutical Science
Domain: Life Sciences
Open Access status: hybrid
APC paid (est): $6,830